Skip to main content Skip to main navigation menu Skip to site footer

Medical Management of Kidney Stones: a review

  • Jody Felizio ,
  • Widi Atmoko ,


Abstract

The incidence of kidney stone disease has been rising in past decades. The prevalence has doubled in both genders, and
the prevalence ratio is shrinking from 3.4 to 1.3 between males and females. This condition greatly impacts individuals, the
health care system, and socioeconomic levels. Kidney stone diseases are related to various risk factors and medical conditions.
A detailed diagnosis through history taking, urinalysis, metabolic evaluation, and stone analysis is important to direct the
therapy approach. The therapy in managing kidney stone diseases comprises dietary and pharmacological treatment. In
addition to general advice on sufficient fluid intake, citrate intake, maintaining ideal body weight, and restricting sodium and
animal protein, the therapy should be adjusted based on the specific type of stones.

Keywords: Kidney stones medical management kidney stone dietary therapy kidney stone pharmacological therapy

References

  1. Afsar B, Kiremit MC, Sag AA, Tarim K, Acar O, Esen T, et al. The role of sodium intake in nephrolithiasis: epidemiology, pathogenesis, and future directions. Eur J Intern Med. 2016;35:16–9. Available from: http://dx.doi.org/10.1016/j.ejim.2016.07.001
  2. Dion M, Ankawi G, Chew B, Paterson R, Sultan N, Hoddinott P, et al. CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update. Can Urol Assoc J. 2016/11/10. 2016;10(11–12):E347–58. Available from: https://pubmed.ncbi.nlm.nih.gov/28096919
  3. Ratkalkar VN, Kleinman JG. Mechanisms of Stone Formation. Clin Rev Bone Miner Metab. 2011;9(3–4):187–97. Available from: https://pubmed.ncbi.nlm.nih.gov/22229020
  4. Jayaraman UC, Gurusamy A. Review on uro-lithiasis pathophysiology and aesculapian discussion. IOSR J Pharm. 2018;8(2):30–42.
  5. Alshara L, Batagello CA, Armanyous S, Gao T, Patel N, Remer EM, et al. The Impact of Thiazides and Potassium Citrate on Bone Mineral Density Evaluated by CT Scan in Stone Formers. J Endourol. 2018;32(6):559–64. Available from: http://dx.doi.org/10.1089/end.2017.0940
  6. Cloutier J, Villa L, Traxer O, Daudon M. Kidney stone analysis: “Give me your stone, I will tell you who you are!” World J Urol. 2014/12/03. 2015;33(2):157–69. Available from: https://pubmed.ncbi.nlm.nih.gov/25465911
  7. Morgan MSC, Pearle MS. Medical management of renal stones. BMJ. 2016;i52. Available from: http://dx.doi.org/10.1136/bmj.i52
  8. Kok DJ. The preventive treatment of recurrent stone-formation: how can we improve compliance in the treatment of patients with recurrent stone disease? Urolithiasis. 2015/12/14. 2016;44(1):83–90. Available from: https://pubmed.ncbi.nlm.nih.gov/26667826
  9. Oka AAG, Dewi AAAOK, Widiana IGR. Validity S.T.O.N.E. nephrolithometry scoring to predict stone free status in kidney stone patients after percutaneous nephrolithotomy. Bali Med J. 2020;9(1):155. Available from: http://dx.doi.org/10.15562/bmj.v9i1.1719
  10. Ramaswamy K, Shah O. Metabolic syndrome and nephrolithiasis. Transl Androl Urol. 2014;3(3):285.
  11. Monga M, Penniston KL, Goldfarb DS. Pocket Guide to Kidney Stone Prevention: Dietary and Medical Therapy. Springer; 2014.
  12. Astroza GM, Neisius A, Tsivian M, Preminger GM, Lipkin ME. Treatment Response in Patients with Stones, and Low Urinary pH and Hypocitraturia Stratified by Body Mass Index. J Urol. 2016;195(3):653–7. Available from: http://dx.doi.org/10.1016/j.juro.2015.09.070
  13. Masterson JH, Woo JR, Chang DC, Chi T, L’Esperance JO, Stoller ML, et al. Dyslipidemia is associated with an increased risk of nephrolithiasis. Urolithiasis. 2014/09/06. 2015;43(1):49–53. Available from: https://pubmed.ncbi.nlm.nih.gov/25193087
  14. Lipkin ME, Preminger GM. Demystifying the medical management of nephrolithiasis. Rev Urol. 2011;13(1):34.
  15. Arowojolu O, Goldfarb DS. Treatment of calcium nephrolithiasis in the patient with hyperuricosuria. J Nephrol. 2014/04/01. 2014;27(6):601–5. Available from: https://pubmed.ncbi.nlm.nih.gov/24687403
  16. Batagello CA, Monga M, Miller AW. Calcium Oxalate Urolithiasis: A Case of Missing Microbes? J Endourol. 2018;32(11):995–1005. Available from: http://dx.doi.org/10.1089/end.2018.0294
  17. Heilberg IP. Treatment of patients with uric acid stones. Urolithiasis. 2015;44(1):57–63. Available from: http://dx.doi.org/10.1007/s00240-015-0843-8
  18. Han H, Segal AM, Seifter JL, Dwyer JT. Nutritional Management of Kidney Stones (Nephrolithiasis). Clin Nutr Res. 2015/07/31. 2015;4(3):137–52. Available from: https://pubmed.ncbi.nlm.nih.gov/26251832
  19. Omar M, Sarkissian C, Jianbo L, Calle J, Monga M. Dipstick Spot urine pH does not accurately represent 24 hour urine PH measured by an electrode. Int Braz J Urol. 2016;42(3):546–9. Available from: https://pubmed.ncbi.nlm.nih.gov/27286119
  20. De SK, Liu X, Monga M. Changing Trends in the American Diet and the Rising Prevalence of Kidney Stones. Urology. 2014;84(5):1030–3. Available from: http://dx.doi.org/10.1016/j.urology.2014.06.037
  21. Attalla K, De S, Monga M. Oxalate Content of Food: A Tangled Web. Urology. 2014;84(3):555–60. Available from: http://dx.doi.org/10.1016/j.urology.2014.03.053
  22. EKERUO WO, TAN YEHH, YOUNG MD, DAHM P, MALONEY ME, MATHIAS BJ, et al. METABOLIC RISK FACTORS AND THE IMPACT OF MEDICAL THERAPY ON THE MANAGEMENT OF NEPHROLITHIASIS IN OBESE PATIENTS. J Urol. 2004;172(1):159–63. Available from: http://dx.doi.org/10.1097/01.ju.0000128574.50588.97
  23. Jung H, Andonian S, Assimos D, Averch T, Geavlete P, Kohjimoto Y, et al. Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease. World J Urol. 2017;35(9):1331–40. Available from: http://dx.doi.org/10.1007/s00345-017-2000-1
  24. Iqbal MW, Youssef RF, Neisius A, Kuntz N, Hanna J, Ferrandino MN, et al. Contemporary Management of Struvite Stones Using Combined Endourologic and Medical Treatment: Predictors of Unfavorable Clinical Outcome. J Endourol. 2016;30(7):771–7. Available from: http://dx.doi.org/10.1089/end.2013.0257

How to Cite

Felizio, J., & Atmoko, W. (2022). Medical Management of Kidney Stones: a review. Bali Medical Journal, 11(1), 127–136. https://doi.org/10.15562/bmj.v11i1.3343
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
2

Total
21

Share

Search Panel

Jody Felizio
Google Scholar
Pubmed
BMJ Journal

Widi Atmoko
Google Scholar
Pubmed
BMJ Journal